Rachel Humphrey
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers 18
- CAR-T cell therapy research 15
- Peptidase Inhibition and Analysis 10
- Viral-associated cancers and disorders 4
- Immunology top 1%
- Immunotherapy and Immune Responses 17
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms 7
- Virology top 5%
-
- Lung Cancer Treatments and Mutations 4
-
- Monoclonal and Polyclonal Antibodies Research 6
- Co-authors
- Axel HoosJedd D. WolchokJeffrey S. WeberF. Stephen HodiSteven O’DayMichele MaioCélèste LebbéOmid Hamid
- Cited by
- OncologyImmunologyCancer Research
- Journals
- Journal of Clinical Oncology (13 papers)Blood (1 paper)JNCI Journal of the National Cancer Institute (2 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Rachel Humphrey
48 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Oncology 4.2k
- Immunology 2.1k
- Cancer Research 607
- Virology 155
- Pulmonary and Respiratory Medicine 1.0k
Countries citing papers authored by Rachel Humphrey
This map shows the geographic impact of Rachel Humphrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Humphrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Humphrey more than expected).
Fields of papers citing papers by Rachel Humphrey
This network shows the impact of papers produced by Rachel Humphrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Humphrey. The network helps show where Rachel Humphrey may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rachel Humphrey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 7 | |
| 2 | 2013 | 145 | |
| 3 | 2013 | 65 | |
| 4 | 2013 | 139 | |
| 5 | 2013 | 2 | |
| 6 | 2011 | 99 | |
| 7 | 2010 | 196 | |
| 8 | 2010 | 27 | |
| 9 | 2010 | 371 | |
| 10 | Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteriabreakdown → | 2009 | 2308 |
| 11 | 2007 | 31 | |
| 12 | 2005 | 4 | |
| 13 | 2002 | 61 | |
| 14 | 2002 | 12 | |
| 15 | 1999 | 41 | |
| 16 | 1998 | 7 | |
| 17 | 1998 | 121 | |
| 18 | 1997 | 58 | |
| 19 | 1995 | 19 | |
| 20 | 1994 | 5 |
About Rachel Humphrey
Rachel Humphrey is a scholar working on Oncology, Immunology and Cancer Research, having authored 50 papers that have together received 5.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (18 papers), Immunotherapy and Immune Responses (17 papers), CAR-T cell therapy research (15 papers), Peptidase Inhibition and Analysis (10 papers), Protease and Inhibitor Mechanisms (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Viral-associated cancers and disorders (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Oncology (4.2k citations), Immunology (2.1k citations) and Cancer Research (607 citations). Rachel Humphrey has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Axel Hoos, Jedd D. Wolchok, Jeffrey S. Weber, F. Stephen Hodi, Steven O’Day, Michele Maio, Célèste Lebbé, Omid Hamid, Michael Binder and Geoffrey Nichol. Their work appears in journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.